Cargando…

Ras Downstream Effector GGCT Alleviates Oncogenic Stress

How cells adapt to oncogenic transformation-associated cellular stress and become fully transformed is still unknown. Here we identified a novel GGCT-regulated glutathione (GSH)-reactive oxygen species (ROS) metabolic pathway in oncogenic stress alleviation. We identified GGCT as a target of oncogen...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Zaoke, Wang, Shixiang, Shao, Yuanyuan, Zhang, Jing, Wu, Xiaolin, Chen, Yuxing, Hu, Junhao, Zhang, Feng, Liu, Xue-Song
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700472/ https://www.ncbi.nlm.nih.gov/pubmed/31400748 http://dx.doi.org/10.1016/j.isci.2019.07.036

Ejemplares similares

Recent Developments in Targeting RAS Downstream Effectors for RAS-Driven Cancer Therapy
por: Tatli, Ozge, et al.
Publicado: (2021)

Knockdown of GGCT inhibits cell proliferation and induces late apoptosis in human gastric cancer
por: Zhang, Wenjie, et al.
Publicado: (2016)

GGCT promotes colorectal cancer migration and invasion via epithelial-mesenchymal transition
por: Huang, Qi, et al.
Publicado: (2020)

Oncogenic EFNA4 Amplification Promotes Lung Adenocarcinoma Lymph Node Metastasis
por: Zhao, Xiangyu, et al.
Publicado: (2022)

MiR-205-5p/GGCT Attenuates Growth and Metastasis of Papillary Thyroid Cancer by Regulating CD44
por: Li, Han-Ning, et al.
Publicado: (2022)

Hyperactivation of EGFR and downstream effector phospholipase D1 by oncogenic FAM83B
por: Cipriano, Rocky, et al.
Publicado: (2013)

Interaction of MRPL9 and GGCT Promotes Cell Proliferation and Migration by Activating the MAPK/ERK Pathway in Papillary Thyroid Cancer
por: Zhang, Hui-Min, et al.
Publicado: (2022)

APOBEC3B and APOBEC mutational signature as potential predictive markers for immunotherapy response in non-small cell lung cancer
por: Wang, Shixiang, et al.
Publicado: (2018)

Mechanisms of Tumor Growth Inhibition by Depletion of γ-Glutamylcyclotransferase (GGCT): A Novel Molecular Target for Anticancer Therapy
por: Kageyama, Susumu, et al.
Publicado: (2018)

A single H/ACA small nucleolar RNA mediates tumor suppression downstream of oncogenic RAS
por: McMahon, Mary, et al.
Publicado: (2019)

Ribosome biogenesis is a downstream effector of the oncogenic U2AF1-S34F mutation
por: Akef, Abdalla, et al.
Publicado: (2020)

Oncogenic RAS-induced senescence in human primary thyrocytes: molecular effectors and inflammatory secretome involved
por: Vizioli, Maria Grazia, et al.
Publicado: (2014)

Antigen presentation and tumor immunogenicity in cancer immunotherapy response prediction
por: Wang, Shixiang, et al.
Publicado: (2019)

Correction: Oncogenic RAS-induced senescence in human primary thyrocytes: molecular effectors and inflammatory secretome involved
por: Vizioli, Maria Grazia, et al.
Publicado: (2022)

The Role of Wild-Type RAS in Oncogenic RAS Transformation
por: Sheffels, Erin, et al.
Publicado: (2021)

An ERK1/2‐driven RNA‐binding switch in nucleolin drives ribosome biogenesis and pancreatic tumorigenesis downstream of RAS oncogene
por: Azman, Muhammad S, et al.
Publicado: (2023)

MicroRNA-135b Promotes Cancer Progression by Acting as a Downstream Effector of Oncogenic Pathways in Colon Cancer
por: Valeri, Nicola, et al.
Publicado: (2014)

The Ins and Outs of RAS Effector Complexes
por: Kiel, Christina, et al.
Publicado: (2021)

Transforming ras oncogenes and multistage carcinogenesis.
por: Balmain, A.
Publicado: (1985)

Ras oncogene mutation in multiple myeloma
Publicado: (1989)

RAS: Striking at the Core of the Oncogenic Circuitry
por: Gimple, Ryan C., et al.
Publicado: (2019)

The RAS-Effector Interface: Isoform-Specific Differences in the Effector Binding Regions
por: Nakhaeizadeh, Hossein, et al.
Publicado: (2016)

The erythropoietin receptor is a downstream effector of Klotho-induced cytoprotection
por: Hu, Ming-Chang, et al.
Publicado: (2013)

Graded inhibition of oncogenic Ras-signaling by multivalent Ras-binding domains
por: Augsten, Martin, et al.
Publicado: (2014)

Tumor RAS Gene Expression Levels Are Influenced by the Mutational Status of RAS Genes and Both Upstream and Downstream RAS Pathway Genes
por: Stephens, Robert M, et al.
Publicado: (2017)

The evolutionary history of effectors downstream of Cdc42 and Rac
por: Cotteret, Sophie, et al.
Publicado: (2002)

Downstream Effectors of ILK in Cisplatin-Resistant Ovarian Cancer
por: Reyes-González, Jeyshka M., et al.
Publicado: (2020)

Friend or Foe: Regulation, Downstream Effectors of RRAD in Cancer
por: Sun, Zhangyue, et al.
Publicado: (2023)

Pan-cancer noncoding genomic analysis identifies functional CDC20 promoter mutation hotspots
por: He, Zaoke, et al.
Publicado: (2021)

Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors
por: Song, Jung Min, et al.
Publicado: (2016)

Micro-RNA-155 is induced by K-Ras oncogenic signal and promotes ROS stress in pancreatic cancer
por: Wang, Peng, et al.
Publicado: (2015)

Glycyrrhetinic acid binds to the conserved P-loop region and interferes with the interaction of RAS-effector proteins
por: Zhang, Yuan, et al.
Publicado: (2019)

Can tumor mutational burden determine the most effective treatment for lung cancer patients?
por: Wang, Shixiang, et al.
Publicado: (2020)

The role of RAS oncogenes in controlling epithelial mechanics
por: Nyga, Agata, et al.
Publicado: (2023)

Synergistic blocking of RAS downstream signaling and epigenetic pathway in KRAS mutant pancreatic cancer
por: Zhang, Xiaofei, et al.
Publicado: (2022)

Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors
por: Platten, Michael, et al.
Publicado: (2015)

Signaling Pathways and Downstream Effectors of Host Innate Immunity in Plants
por: Kumar, Jitendra, et al.
Publicado: (2021)

Direct recognition of pathogen effectors by plant NLR immune receptors and downstream signalling
por: Chen, Jian, et al.
Publicado: (2022)

Activated Ras alters lens and corneal development through induction of distinct downstream targets
por: Burgess, Daniel, et al.
Publicado: (2010)

Sos-mediated cross activation of wild-type Ras by oncogenic Ras is essential for tumorigenesis
por: Jeng, Hao-Hsuan, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_dmt8v6uocoedoo9iunbsq7ntpm